Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The next-generation AAV vectors are fueling gene therapy. By combining state-of-the-art knowledge of biology, directed evolution, and data science, Capsigen is engineering novel AAV capsids to address difficult-to-treat diseases. With highly diverse libraries using the most clinically relevant models, Capsigen is delivering fit-for-purpose vectors designed for tomorrow’s medicine—today. Capsigen is a leader in the engineer...
The next-generation AAV vectors are fueling gene therapy. By combining state-of-the-art knowledge of biology, directed evolution, and data science, Capsigen is engineering novel AAV capsids to address difficult-to-treat diseases. With highly diverse libraries using the most clinically relevant models, Capsigen is delivering fit-for-purpose vectors designed for tomorrow’s medicine—today. Capsigen is a leader in the engineering of AAV capsids for use in gene therapies, opening the path to permanent cures for patients suffering from intractable illness.

List your booth number for exhibitions, ask us